Neuropeptide Y (NPY), a 36 amino acid peptide first isolated from porcine brain [l] , is widely distributed in the central and peripheral nervous system where it is thought to act as a neurotransmitter or neuromodulator [2] . It has potent direct and indirect vasoconstrictor properties [ 31 and may have a physiological role in cardiovascular rqulation [4] . m-localized with noradrenaline in sympathetic nerve terminals [5] although it is also present i n intrinsic cardiac neurones devoid of noradrenaline [6] . NPY exerts its effects through specific receptors located both pre-and post-synaptically, and, on the basis of their affinity for C-terminal Npy fragments, two subtypes of receptor have been identified, Y1 and Yi [7] . Recently, an NPY bindsite has been characterized on rat cardiac ventricular membranes which, although similar to the Y, receptor in its affinity for the C-terminal fragment , is distinguished by its lack of affinity for the related peptide, PYY [8] . This supyrts the contention that NPY can exert some of its cardiac effects directly, through interaction w i t h this Ys receptor. determine potential routes for the inactivation of Npy in cardiac membranes (essential for its role as a neurotransmitter), and to identify NPY degradation products which may have selective affinity for the NFY receptor subtypes [9] .
Cardiac membranes were prepared from rat heart as described [8] , but omitting peptidase inhibitors ( m F , EDTA). The final pellet was resuspended in 5 m TrispiC1 (pm .4) .
with membrane (2mg protein) in Iml of TrispiCl (p~1.4) at 37". The reaction was stopped at various time points up to 5h by adding TFA (1% final conc). m-oducts were separated by reversed phase H P E on Nova-Pak C18 cartridge eluting with 3-70% acetonitrile gradient (30 min; 2ml/min) containing 1 M TFA, and identified by amino acid analysis (Waters Pic0 Tag methd). tissue fraction for 5 min before adding NFY.
In the PNS, NPY is mainly 'Ihe purpose of this study w a s twofold: to NPY (1OOpg) was incubat& Inhibitors were preincubated with -2, 3-36, 3-30, 3-27, 3-20, 31-36, 32-36 300 3-30, 3-27, 3-26, 3-23, 3-22, 3-21, 3-20, 3-19, 6-19, 1-2, 3-11, 4-5, 12-14 TWO mjor degradation products were identified
The formation of %-Pro from NPY under at the earliest time pint, Tyr-Pro and NPY(3-36) ( Table 1) . these anditions was inhibited by diprotin A and Zn*, partially inhibited by 2mM R%F but not affected by puromycin or EDTA/MT (see Table 2 ). 'Ihus the specificity and inhibitor characteristics of the cleavage are consistent with the action of dipeptidylpeptidase IV [lo] . The two products fonnd by hydrolysis of the I .~u~~-I l e~~ bond (see Fig 1) in NPY , ie and (31) (32) (33) (34) (35) (36) were detected in the 30 m i n incubation (Table 1) . Other products (3-27, 3-20, 3-19 etc) are probably derived from , since the equivalent full length C-terminal prcflucts were not detected. Differential effects of inhibitors were seen on the formation of these secondary pmxiucts (30 m i n incubation; Table 1 ). 'Ihus, R E F inhibited overall degradation by 66%, selectively inhibiting the formation of , , (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) and (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) , indicating that a chymtrypsin-like enzyme (possibly chyr~se) plays a major role in the secondary degradation. U r T had no overall inhibitory effect, but increased and (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) at the expense of . E m A had no overall inhibitory effect, but increased the w u n t s of and (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) formed, by inhibiting their degradation. Thiorphan, captopril and bestatin had no effect at all. The degradation of NPY by rat brain synaptic membranes was ten fold slower (per r q protein) than by cardiac membranes; the main initial product w a s NFY(1-30) and, in contrast to the cardiac membranes, removal of the N-terminal Wr-Pro was not seen.
and synaptic membranes would inactivate NPY. it is not clear whether removal of the N-terminal W-Pr-0 is significant in the inactivation process. would bc a full agonist at Y2 receptors [9] ; there is however evidence that is an antagonist at Y3 receptors in rat heart [8, 9] and it would be of interest to test for similar activity.
The cleavage at L e~~~-I l e~' in cardiac However 
